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Original Article
Retinopathy of Prematurity: Frequency and Risk Factors in a Tertiary Care
Hospital in Karachi, Pakistan
Ather M Taqui1, Reema Syed2, Tanveer A Chaudhry3, Khabir Ahmad4, Muhammad S Salat5
Department of Surgery1,2,3,4, Department of Pediatrics5, Aga Khan University, Karachi, Pakistan.
Abstract
Introduction: To determine the frequency of Retinopathy of Prematurity (ROP) in the premature infants born in
a tertiary care hospital and to determine the risk factors associated with it. 
Methods: This was a retrospective analysis of premature infants with birth weight < 1500 grams or gestational
age < 32 weeks, admitted to the Neonatal Intensive Care Unit of a tertiary care hospital in a three year period.
The infants underwent eye examinations between their 4th and 7th week of life. Univariate and multiple logistic
regression analysis were performed to determine the association between risk factors and ROP development.
Results: Sixty eight infants were included in the analysis. Out of these, 22 (32.4%) developed ROP (inclusive of
all stages) and 14 (20.6%) developed threshold disease. Multiple logistic regression analysis revealed that low
gestational age, sepsis and respiratory distress syndrome were independent predictors for the development of
ROP. 
Conclusion: The frequency of ROP in our hospital was on the higher side of the range reported in neighbouring
developing countries. Low gestational age, sepsis and respiratory distress syndrome were independent
predictors of ROP development. Our results suggest that ROP is an important emerging cause of preventable
childhood blindness in urban areas of Pakistan like Karachi (JPMA 58:186;2008).
Introduction
Retinopathy of prematurity (ROP) is a vaso-
proliferative disorder of the eye affecting preterm infants
which can progress to cause visual impairment or blindness.
Recent advances in neonatal care in the last decade, have
improved the survival rates for premature infants.1
Consequently, the incidence of ROP has increased in
parallel.2,3 ROP is an important cause of childhood
blindness in both developed4 and developing countries.3,5
This view is also expressed by the World Health
Organization's "Vision 2020 programme".
Research has identified several factors which have
been shown to have some causal association with ROP.
However, three factors have shown consistent and
significant association with ROP: low gestational age, low
birth weight and prolonged exposure to supplementary
oxygen following delivery.6,7 Other putative risk factors
include mechanical ventilation8, sepsis6,9, intraventricular
haemorrhage6, surfactant therapy7,10, anaemia11, high
number of blood transfusions11, apnoea7,9, male gender and
poor postnatal weight gain. It is difficult to determine
whether these factors are actual predictors of ROP or if they
reflect the severity of illness.
Although screening criteria have been suggested by
various international institutions12,13; variations in quality of
neonatal care facilities, socioeconomic status of patients,
accessibility of services and awareness about ROP lead to
variations in incidence of ROP in the same country.
Therefore, it is imperative that studies be conducted to
complement adapted screening programmes in each
country. It is equally important to revise these criteria
regularly. A number of studies, prospective as well as
retrospective6-8 have been done in developed countries to
find out the frequency and specific features of ROP present
in their own populations. 
Pakistan is a developing country with poor health
indicators. It is currently the sixth most populous country in
the world.14 The majority of the population (66%)14 lives in
rural areas. Intensive care facilities for premature infants are
costly and specialized services are less likely to be
established in remote and rural areas. Therefore, survival
rates for premature neonates in these rural areas are low and
ROP is not a significant cause of blindness there. However,
in the urban cities where adequate neonatal care facilities
are available, it can be predicted that ROP will emerge as an
important cause of childhood blindness. 
In the light of the above background, we decided to
conduct a study to determine the incidence of ROP in the
premature infants born in our hospital and to determine the
risk factors associated with ROP. 
Subjects and Methods
This retrospective study was conducted in the Aga
Khan University Hospital (AKUH), a private tertiary care
186 J Pak Med Assoc
hospital in Karachi. AKUH is located in the heart of the city
and it draws patients from all over Karachi. AKUH has a
busy Neonatal Intensive Care Unit (NICU) with excellent
facilities. The Unit contains 10 intensive care unit cots. 
This was a retrospective analysis of premature
infants with birth weight < 1500g and/or gestational age <
32 weeks, admitted to the NICU of the AKUH between
March 2003 and September 2006. These inclusion criteria
were derived from the established screening criteria
proposed by the British Royal College of
Ophthalmologists.13 However, we used the gestational age
cut off of 32 weeks rather than 31 weeks.
Our exclusion criteria were defined as 1) infants who
died before sufficient number of eye examinations could be
done to diagnose ROP, 2) infants who were not referred for
eye examination although they satisfied the inclusion
criteria, 3) infants who were lost to follow up before
sufficient number of eye examinations could be done to
either rule out ROP or see the progression/regression of
established ROP.
Perinatal and neonatal data on risk factors and course
in hospital were retrieved from the infants' medical records.
The premature infants satisfying the above criteria
underwent initial eye examinations on the 4th-7th week of
life. All eye examinations were carried out by TAC. The
stages of ROP were classified according to the International
Classification of Retinopathy.15
If no ROP was noted, eye examinations were
continued every 2 weeks until normal vascularisation of the
retina had occurred. The infants with ROP were screened at
intervals dictated by the severity of the disease, until the
retinal vessels matured or the infant developed threshold
ROP. All infants with threshold ROP were treated with
argon laser therapy using indirect ophthalmoscopy. Follow-
up examinations were done after laser treatment to confirm
regression of disease.
Eyes were examined using 0.5% tropicamide and
2.5% phenylephrine eye drops after 3 insructions, 15
minutes apart. Binocular indirect ophthalmoscopy was
performed using a 20 D lens. Lid speculum and scleral
depressors were routinely used.
The data was entered in Epi Data version 3.1 and
analyzed in Statistical Package for Social Sciences (SPSS)
14.0. Descriptive statistics were performed. Results were
recorded as frequencies, means ± standard deviations (SD)
and P values. Tables and figures were used for
comprehensive viewing of the results. 
Univariate comparison of the risk factors was done
between the groups of infants who developed ROP versus
those who did not by the Chi square test and Fisher's exact
test for categorical variables and the independent samples t-
test for continuous variables. The variables which achieved
significance (p<0.25) on univariate analysis or were
biologically meaningful were subjected to a stepwise
multiple logistic regression analysis to determine which
factors were independent predictors of the development of
ROP. Unadjusted as well as adjusted odds ratios were
recorded with a 95% confidence interval for each. Unless
stated otherwise, a p<0.05 was taken as the criteria of
significance for all purposes.
Results
At birth, a total of 164 infants fulfilled the screening
criteria. Out of these, 48 expired before reaching the age for
screening of ROP and 36 were not referred even though
they fulfilled the screening criteria. After applying all the
exclusion criteria, 68 infants were included in the analysis. 
Of the 68 infants, 35 (51.5%) were male. The mean
gestational age (GA) of the infants was 29.8 + 2.2 weeks
and the mean body weight (BW) was 1235 + 281 grams.
Out of the 68 infants, 22 (32.4%) developed ROP.
Seventeen (77.3%) of the 22 ROP positive infants had pre-
threshold disease at the initial screening while 5 (23.7%)
had threshold disease. Eight (47.1%) of the 17 babies
showed spontaneous regression in a mean period of 4
weeks, 9 (53.0%) progressed to threshold disease in an
average of 2 weeks. Fourteen out of the 68 infants (20.6%)
developed Stage 3 ROP. All patients who developed
threshold disease underwent retinal photocoagulation
within 72 hours of diagnosis except for one due to non-
affordability. All of those treated with photocoagulation
showed regression of disease on follow-up examinations
and none of them therefore required another round of laser
treatment.
Table 1. Incidence and stage distribution of ROP according to
gestational age, birth weight and duration of supplemental oxygen.
Risk Factor ROP+ ROP-
P
value*
Stage 
1 2 3
Gestational age (weeks)
< 28
> 28 
Birth weight (grams)
< 1000
> 1000
Supplemental oxygen 
duration (days)
0
< 5
> 5
10 (66.7)
12 (22.6)
10 (71.4)
12 (22.2)
1 (6.7)
5 (17.9)
16 (64.0)
5 (33.3)
41 (77.4)
4 (28.6)
42 (77.8)
14 (93.3)
23 (82.1)
9 (36)
0.002
0.001
<0.001
2
4
2
4
0
0
6
0
2
0
2
0
2
0
8
6
8
6
1
3
10
* The chi square test and Fisher's exact test were applied.
+ There were no infants with ROP at Stage 4 or 5.
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The infants had their first screening in the 4th-7th
day of life. ROP was first detected at 4-11 weeks (mean =
6.7 ± 1.5 weeks) of life. ROP stage 3 was first detected at a
post-natal age of 5-11 weeks (mean = 7.9 ± 1.9 weeks). 
Table 1 shows the incidence and stage distribution of
ROP according to GA, BW and supplemental oxygen
duration. A significantly higher proportion of infants of GA
< 28 weeks developed ROP compared to infants of GA > 28
weeks (66.7% vs. 22.6%, p = 0.002). When comparing birth
weight, it was seen that a significantly higher proportion of
infants with BW < 1000 g developed ROP compared to
infants with BW > 1000 g (71.4% vs. 22.2%, p = 0.001).
When looking at the stage distribution, it was found that
advanced cases of ROP occurred more frequently in the
lower BW, lower GA and greater duration of supplemental
oxygen therapy groups.
Table 2 shows the univariate comparison of risk
factors between the group of infants which developed ROP
versus those who did not. Based on the univariate analysis,
the following risk factors were chosen to be included in the
stepwise multiple regression model: GA, BW, supplemental
oxygen duration, duration of mechanical ventilation, the
number of blood transfusions, sepsis, respiratory distress
syndrome, surfactant therapy, anaemia, patent ductus
arteriosus, intraventricular haemorrhage and hypotension
requiring ionotropic support. The final multiple regression
model (Table 3) included three independent predictors of
the development of ROP: low GA (AOR = 0.6, [95% CI:
0.4-0.8]), sepsis (AOR = 11.2, [95% CI: 2.5 - 50.8] and
respiratory distress syndrome (AOR = 14.3, [95% CI: 1.8-
116.3]).
Discussion
The present study showed that the incidence of ROP
in the premature infants in our hospital was 32.4%. This
value was within the range seen in other studies. In the
developed countries, reported ROP incidence ranges from
13.2-46%.6,16,17 There is a paucity of literature from
developing countries as compared to developed countries,
probably because ROP has just started emerging as an
important cause of childhood blindness. In countries like
Thailand, Philippines, Chile and west Africa, ROP is not
reported in rural areas but causes 15-16.6% of visual loss in
Table 2. Univariate comparison of risk factors
Risk Factor
ROP+ (n=22)
Mean+SD
or n (%)
ROP-  (n=46)
Mean+SD
or n (%)
Unadjus
ted OR*
95% CI+
Gestational age (P value < 0.001)
28.2 + 2.0 wks 30.5 + 1.9 wks
Birth weight (P value = 0.001)
1073 + 274 g 1312 + 251 g
Duration of supplemental oxygen therapy (P value < 0.001)
19.3 + 18.9 days 3.2 + 4.1 days
Mechanical ventilation (P value < 0.001)
18.6 + 17.0 days 4.6 + 7.2 days
Number of blood transfusions (P value < 0.001)
16.2 + 12.0 6.2 + 9.6
Gender (P value = 0.726)
Female
Male
10 (45.5%)
12 (54.5%)
23 (50%)
23 (50%)
1
1.2 0.4-3.3
Sepsis (P value = 0.001)
No
Yes
6 (27.3%)
16 (72.7%)
34 (73.9%)
12 (26.1%)
1
7.6 2.4-23.7
Respiratory Distress Syndrome (P value = 0.006)
No
Yes
2 (9.1%)
20 (90.9%)
22 (47.8%)
24 (52.2%)
1
9.2 1.9-43.8
Surfactant therapy (P value = 0.061)
No
Yes
7 (31.8%)
15 (68.2%)
26 (56.5%)
20 (43.5%)
1
2.8 1.0-8.1
Anemia (P value = 0.167)
No
Yes
4 (18.2%)
18 (81.8%)
16 (34.8%)
30 (65.2%)
1
2.4 0.7-8.3
Intaventricular haemorrhage (P value = 0.022)
No
Yes
17 (77.3%)
5 (22.7%)
45 (97.8%)
1 (2.2%)
1
13.2 1.4-121.7
Patent Ductus Arteriosus (P value = 0.154)
No
Yes
13 (59.1%)
9 (40.9%)
35 (76.1%)
11 (23.9%)
1
2.2 0.7-6.5
Patent Foramen Ovale (P value = 0.534)
No
Yes
19 (86.4%)
3 (13.6%)
42 (91.3%)
4 (8.7%)
1
1.7 0.3-8.1
Hypotension requiring ionotropic support (P value = 0.098)
No
Yes
19 (86.4%)
3 (13.6%)
45 (97.8%)
1 (2.2%)
1
7.1 0.7-72.7
Apnoea (P value = 0.623)
No
Yes
15 (68.2%)
7 (33.8%)
34 (73.9%)
12 (26.1%)
1
1.3 0.4-4.0
* OR = Odds ratio
+ CI = Confidence Interval
The independent samples t-test was used for continuous variables. The chi-square test and
Fisher's exact test was used for categorical variables
Table 3. Multiple logistic regression analysis showing independent
predictors of ROP development
Risk Factor P value Adjusted OR* 95% CI+
Gestational age
Sepsis
Respiratory distress syndrome
0.004
0.002
0.013
0.6
11.2
14.3
0.4-0.8
2.5-50.8
1.8-116.3
OR = Odds ratio
+ CI = Confidence Interval
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the cities where better medical facilities are available.18,19 In
India, which is a comparable country to Pakistan in terms of
socioeconomic and demographic aspects, reported rates
vary from 20-47.3%.9,20,21 The value of incidence (32.4%)
in our study was on the higher side of the range reported in
comparable developing countries. However, caution must
be exercised when comparing with other studies due to
differences in methodologies and selection criteria. 
A high proportion of infants of GA < 28 weeks
developed ROP (66.7%). This was similar to a study done
in India by Karna et al, which reported that 66% of infants
of GA < 28 weeks developed ROP10 and another study done
in Sweden which reported a rate of 65.5%.22 A high
proportion of infants with BW < 1000g developed ROP
(71.4%). This value was similar to those reported by a study
done in Sweden22 and one in Saudi Arabia23 (72.2% and
76.9% respectively). However, it was higher than the
incidence of 53.4% reported by a study done in Korea.7 The
CRYO-ROP study reported an incidence of 81.6% in infants
with BW < 1000g.24 This wide variation in the incidence of
ROP according to BW and GA could reflect racial and
geographical differences. In addition, these variations can
also be explained by differences in study designs and
methodologies. It highlights the importance of conducting
studies to find out the cost-effective screening cutoffs of GA
and BW in each region. 
Stepwise multiple logistic regression analysis
revealed that only three risk factors were independent
predictors of the development of ROP: low gestational age,
sepsis and respiratory distress syndrome. It is well-
established that prematurity is the most significant risk
factor in the development of ROP and it has been shown to
be an independent predictor.10 Sepsis has been identified as
an independent predictor of ROP development in many
Asian studies including Indian studies.9,20 Respiratory
distress syndrome has also been shown to be an independent
predictor of ROP development.25
It is imperative for studies to explore the association
between ROP and risk factors other than the three well
recognized risk factors: low GA, low BW and supplemental
oxygen. This is especially important for developing
countries because it is known that larger, more mature
infants are developing advanced ROP in countries with low
levels of development compared to developed countries.5 A
plausible explanation for this observation is that risk factors
like sepsis which is more prevalent in developing countries,
account for the advanced ROP in infants with relatively
large GA and good BW.
While interpreting the findings of this study, the
following limitations should be kept under consideration. A
large number of infants (36) who satisfied the inclusion
criteria were excluded mainly because they were not
referred to an ophthalmologist for screening. Therefore, we
could not determine whether they developed ROP or not.
The sample size left in the end for analysis was
consequently small. These factors could lead to an under- or
overestimation of the true incidence of ROP. The present
study had one disturbing revelation. Out of the large number
of infants who satisfied inclusion criteria for screening but
somehow remained unscreened, a few could have
developed ROP and consequently blindness. This highlights
the dire need for implementation of proper screening
guidelines so that appropriate and prompt referral of high
risk infants occurs. In order to develop cost-effective
screening guidelines, prospective multi-centre studies need
to be carried out in the country. 
Conclusion
The incidence of ROP in our hospital was on the
higher side of the range reported in neighbouring
developing countries. Since the hospital caters to the
population of Karachi, it can be postulated that ROP is an
important emerging cause of preventable childhood
blindness. It is imperative that screening guidelines be
implemented in all hospitals with neonatal care facilities.
ROP is currently under recognized and awareness needs to
be increased among all doctors and parents of premature
infants. There is a need for large prospective multi-centre
studies to be conducted to determine the true incidence of
ROP in Pakistan and to lay down cost-effective region
specific screening guidelines for ROP.
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Abstract
Introduction: To determinate the knowledge on osteoporosis-risk factors and disease in three age groups of
Pakistani women.
Methods: In this exploratory cross-sectional study, an osteoporosis knowledge assessment questionnaire
(OKAT) was used to collect data and it was delivered through a face-to-face interview. Questions were asked
about symptoms of osteoporosis, knowledge of risk factors, preventive factors and treatment. A convenience
sample (n =320) comprising of three groups of healthy women aged 25-35 years, 36-45 years, and over 45 years
was taken. The scoring range was 0 to 20. Among-group comparisions of means were analyzed by two-way
ANOVA. To determine the overall influence of osteoporosis-risk factors, the multivariate analysis was used.
Results: The knowledge on osteoporosis in younger women was very poor compared to relatively older females.
However, women belonging to higher socioeconomic status and better education had slightly more knowledge
about osteoporosis compared to those with a low education level, regardless of age. 
Conclusion: The majority of women had modest knowledge on osteoporosis. Younger women were at increased
risk for low bone mass and premature osteoporosis (JPMA 58:190;2008).
Introduction
Osteoporosis is a major and growing public health
problem in both sexes but particularly in women.1,2 It is a
systemic skeletal disorder, characterized by reduction of
bone mass, deterioration of bone structure, increasing bone
fragility, and increasing fracture risk.3-5 It is a major cause
of fractures in elderly, resulting in pain, disability, costly
rehabilitation, poor quality of life, and premature death.6
Developing countries continue to be ill-equipped to
handle burden of the disease. This coupled with poor
literacy rates and lack of awareness on the risk factors and
symptoms results in poor outcomes.7
Several risk factors for osteoporosis have been
identified. These include female sex, Asian or Caucasian
race, advancing age, family history of osteoporosis or
fragility fractures, a low body mass index, menopause
before age 45 years, prolonged amenorrhea unrelated to
menopause, nulliparity, prolonged lactation, diet low in
calcium and vitamin D, poor intestinal absorption of
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